MedTrace Logo

Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device

NCT00361608 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-07-19

No results posted yet for this study

Summary

This study observes the continuous measurement of breathing patterns, heart rate, restlessness, and tremor in sleep using the EarlySense ES 16 device as a tool in the management of hypoglycemia in pediatric type I diabetes patients.

Conditions

  • Type I Diabetes

Interventions

DEVICE

EarlySense ES 16

Sponsors & Collaborators

  • Schneider Children's Medical Center, Israel

    collaborator OTHER

  • EarlySense Ltd.

    lead INDUSTRY

Principal Investigators

  • Liat de Vries, M.D. · Schneider Children's Medical Center, Israel

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00361608 on ClinicalTrials.gov